Systematic review / meta-analysis / 2019
Oral turmeric and curcumin did not significantly lower inflammatory markers in chronic inflammatory conditions.
A systematic review and meta-analysis of 19 randomized controlled trials with follow-ups from 4 to 16 weeks examined oral turmeric (5 trials, n = 356) and curcumin (14 trials, n = 988). Compared to controls, interventions did not significantly lower CRP (MD -2.71 mg/L, 95% CI -5.73 to 0.31), hsCRP (MD -1.44 mg/L, 95% CI -2.94 to 0.06), IL-1 beta, IL-6, or TNF alpha. High heterogeneity was observed for most markers.
- Study type
- Systematic review and meta-analysis of randomized controlled trials
- Who was studied
- 1,344 patients across 19 randomized controlled trials with chronic inflammatory diseases
- What was measured
- Inflammatory markers (CRP, hsCRP, IL-1, IL-6, TNF)
THE PAPER
Oral turmeric/curcumin effects on inflammatory markers in chronic inflammatory diseases: A systematic review and meta-analysis of randomized controlled trials.
White CM, Pasupuleti V, Roman YM, Li Y, Hernandez AV. Pharmacol Res, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.